• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素通过干扰成熟破骨细胞的有机骨基质降解活性来降低吸收陷窝的深度。

Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.

作者信息

Parikka V, Lehenkari P, Sassi M L, Halleen J, Risteli J, Härkönen P, Väänänen H K

机构信息

Institute of Biomedicine, Department of Anatomy and Medicity Research Laboratory, University of Turku, FIN-20520 Turku, Finland.

出版信息

Endocrinology. 2001 Dec;142(12):5371-8. doi: 10.1210/endo.142.12.8533.

DOI:10.1210/endo.142.12.8533
PMID:11713237
Abstract

Decreased E2 levels after menopause cause bone loss through increased penetrative resorption. The reversal effect of E2 substitution therapy is well documented in vivo, although the detailed mechanism of action is not fully understood. To study the effects of E2 on bone resorption, we developed a novel in vitro bone resorption assay in which degradation of inorganic and organic matrix could be measured separately. E2 treatment significantly decreased the depth of resorption pits, although the area resorbed was not changed. Electron microscopy further revealed that the resorption pits were filled with nondegraded collagen, suggesting that E2 disturbed the organic matrix degradation. Two major groups of proteinases, matrix metalloproteinases (MMPs) and cysteine proteinases, have been suggested to participate in organic matrix degradation by osteoclasts. We show here that MMP-9 released a cross-linked carboxyl-terminal telopeptide of type I collagen from bone collagen, and cathepsin K released another C-terminal fragment, the C-terminal cross-linked peptide of type I collagen. E2 significantly inhibited the release of the C-terminal cross-linked peptide of type I collagen into the culture medium without affecting the release of cross-linked carboxyl-terminal telopeptide of type I collagen in osteoclast cultures. These results suggest that organic matrix degradation is initiated by MMPs and continued by cysteine proteases; the latter event is regulated by E2.

摘要

绝经后雌激素(E2)水平降低通过增加穿透性骨吸收导致骨质流失。E2替代疗法的逆转作用在体内已有充分记录,尽管其详细作用机制尚未完全明确。为了研究E2对骨吸收的影响,我们开发了一种新型的体外骨吸收测定法,可分别测量无机和有机基质的降解情况。E2处理显著降低了吸收陷窝的深度,尽管吸收面积未改变。电子显微镜进一步显示,吸收陷窝内充满了未降解的胶原蛋白,这表明E2干扰了有机基质的降解。已有研究表明,两组主要的蛋白酶,即基质金属蛋白酶(MMPs)和半胱氨酸蛋白酶,参与破骨细胞对有机基质的降解。我们在此表明,MMP-9从骨胶原蛋白中释放出I型胶原蛋白的交联羧基末端肽段,组织蛋白酶K释放出另一个C末端片段,即I型胶原蛋白的C末端交联肽段。在破骨细胞培养中,E2显著抑制I型胶原蛋白C末端交联肽段释放到培养基中,而不影响I型胶原蛋白交联羧基末端肽段的释放。这些结果表明,有机基质的降解由MMPs启动,由半胱氨酸蛋白酶继续进行;后者受E2调节。

相似文献

1
Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.雌激素通过干扰成熟破骨细胞的有机骨基质降解活性来降低吸收陷窝的深度。
Endocrinology. 2001 Dec;142(12):5371-8. doi: 10.1210/endo.142.12.8533.
2
Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.破骨细胞性骨降解以及不同半胱氨酸蛋白酶和基质金属蛋白酶的作用:颅骨与长骨之间的差异
J Bone Miner Res. 2006 Sep;21(9):1399-408. doi: 10.1359/jbmr.060614.
3
The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.半胱氨酸蛋白酶和基质金属蛋白酶对源自长骨和肩胛骨的破骨细胞吸收过程的相对贡献。
Bone. 2004 Oct;35(4):909-17. doi: 10.1016/j.bone.2004.06.002.
4
Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.破骨细胞对骨有机相的降解:溶酶体酸化的次要作用。
J Bone Miner Res. 2006 Jan;21(1):58-66. doi: 10.1359/JBMR.050905. Epub 2005 Sep 6.
5
Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.人骨髓间充质干细胞来源的成骨细胞在体外通过基质金属蛋白酶降解有机骨基质。
Matrix Biol. 2005 Sep;24(6):438-47. doi: 10.1016/j.matbio.2005.06.009.
6
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.强效且选择性地抑制人组织蛋白酶K可导致非人类灵长类动物体内骨吸收受到抑制。
J Bone Miner Res. 2001 Oct;16(10):1739-46. doi: 10.1359/jbmr.2001.16.10.1739.
7
Regulation and enzymatic basis of bone resorption by human osteoclasts.人类破骨细胞骨吸收的调节及酶学基础
Clin Sci (Lond). 2007 Jun;112(11):567-75. doi: 10.1042/CS20060274.
8
Matrix collagen of devitalized bone is resistant to osteoclastic bone resorption.失活骨的基质胶原蛋白对破骨细胞的骨吸收具有抗性。
Connect Tissue Res. 1989;20(1-4):169-75. doi: 10.3109/03008208909023885.
9
Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.组织蛋白酶K活性依赖性调节破骨细胞肌动蛋白环形成和骨吸收。
J Biol Chem. 2009 Jan 23;284(4):2584-92. doi: 10.1074/jbc.M805280200. Epub 2008 Nov 21.
10
The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.组织蛋白酶 K 抑制剂odanacatib 对破骨细胞骨吸收和囊泡转运的影响。
Bone. 2011 Oct;49(4):623-35. doi: 10.1016/j.bone.2011.06.014. Epub 2011 Jun 22.

引用本文的文献

1
Progranulin deficiency associates with postmenopausal osteoporosis via increasing ubiquitination of estrogen receptor α.颗粒蛋白前体缺乏通过增加雌激素受体α的泛素化作用与绝经后骨质疏松症相关联。
Genes Dis. 2024 Jan 28;12(1):101221. doi: 10.1016/j.gendis.2024.101221. eCollection 2025 Jan.
2
Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.蛋白水解调控半乳糖凝集素-3/Lrp1 轴控制破骨细胞介导的骨吸收。
J Cell Biol. 2023 Apr 3;222(4). doi: 10.1083/jcb.202206121. Epub 2023 Mar 2.
3
Interleukin-23 Regulates Inflammatory Osteoclastogenesis via Activation of CLEC5A(+) Osteoclast Precursors.
白细胞介素-23 通过激活 CLEC5A(+)破骨细胞前体调节炎症性破骨细胞生成。
Arthritis Rheumatol. 2023 Aug;75(8):1477-1489. doi: 10.1002/art.42478. Epub 2023 Jun 6.
4
Effects of Vitamin A (Retinol) Release from Calcium Phosphate Matrices and Porous 3D Printed Scaffolds on Bone Cell Proliferation and Maturation.钙磷基质和多孔 3D 打印支架中维生素 A(视黄醇)释放对骨细胞增殖和成熟的影响。
ACS Appl Bio Mater. 2022 Mar 21;5(3):1120-1129. doi: 10.1021/acsabm.1c01181. Epub 2022 Mar 8.
5
Novel population of human monocyte and osteoclast progenitors from pluripotent stem cells and peripheral blood.新型多能干细胞和外周血来源的人单核细胞和破骨细胞祖细胞群体。
Blood Adv. 2021 Nov 9;5(21):4435-4446. doi: 10.1182/bloodadvances.2021004552.
6
The Mechanism Switching the Osteoclast From Short to Long Duration Bone Resorption.将破骨细胞从短期骨吸收转换为长期骨吸收的机制。
Front Cell Dev Biol. 2021 Mar 30;9:644503. doi: 10.3389/fcell.2021.644503. eCollection 2021.
7
Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.衰老和更年期会对破骨细胞前体进行重编程,以促进活跃的骨吸收。
Bone Res. 2020 Jul 1;8:27. doi: 10.1038/s41413-020-0102-7. eCollection 2020.
8
Anti‑chondrocyte apoptosis effect of genistein in treating inflammation‑induced osteoarthritis.金雀异黄素治疗炎症性骨关节炎抗软骨细胞凋亡作用。
Mol Med Rep. 2020 Sep;22(3):2032-2042. doi: 10.3892/mmr.2020.11254. Epub 2020 Jun 18.
9
Osteoporosis and the Potential of Cell-Based Therapeutic Strategies.骨质疏松症与基于细胞的治疗策略的潜力。
Int J Mol Sci. 2020 Feb 28;21(5):1653. doi: 10.3390/ijms21051653.
10
Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.破骨细胞介导的骨吸收受分泌型和膜结合型金属蛋白酶的补偿性网络控制。
Sci Transl Med. 2020 Feb 5;12(529). doi: 10.1126/scitranslmed.aaw6143.